Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial-Reference-Cited by-同舟云学术

Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial

Published:2023-02 Issue:2 Volume:164 Page:241-255
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Rath Timo,Atreya Raja,Bodenschatz Julia,Uter Wolfgang,Geppert Carol E.,Vitali Francesco,Fischer Sarah,Waldner Maximilian J.,Colombel Jean-Frédéric,Hartmann Arndt,Neurath Markus F.

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference60 articles.

1. Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn’s disease;Shah;Aliment Pharmacol Ther,2016

2. Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis;Shah;Clin Gastroenterol Hepatol,2016

3. Selecting end points for disease-modification trials in inflammatory bowel disease: the SPIRIT consensus from the IOIBD;Le Berre;Gastroenterology,2021

4. Results from the 2nd Scientific Workshop of the ECCO. I: impact of mucosal healing on the course of inflammatory bowel disease;Peyrin-Biroulet;J Crohns Colitis,2011

5. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target;Peyrin-Biroulet;Am J Gastroenterol,2015

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The JNK/P38 signalling pathway activated by testin protects the intestinal epithelial barrier against Crohn's disease-like colitis;Chemico-Biological Interactions;2024-11

2. Oral delivery of sodium alginate/chitosan bilayer microgels loaded with Lactobacillus rhamnosus GG for targeted therapy of ulcerative colitis;International Journal of Biological Macromolecules;2024-10

3. To STRIDE or not to STRIDE: a critique of “treat to target” in ulcerative colitis;Expert Review of Gastroenterology & Hepatology;2024-08-28

4. Endocytoscopy with automated multispectral intestinal barrier pathology imaging for assessment of deep healing to predict outcomes in ulcerative colitis;Gut;2024-08-06

5. Deep mucosal healing in ulcerative colitis: how deep is better?;Frontiers in Medicine;2024-08-02